Evaluation of predictive biomarkers and resistance mechanisms of PI3K pathway inhibition in head and neck squamous cell carcinoma

被引：0
|
作者：
Mazumdar, Tuhina [1 ]
Byers, Lauren A. [1 ]
Ng, Patrick [1 ]
Mills, Gordon B. [1 ]
Peng, Shaohua [1 ]
Diao, Lixia [1 ]
Fan, Youhong [1 ]
Stemke-Hale, Katherine [1 ]
Heymach, John V. [1 ]
Myers, Jeffrey N. [1 ]
Glisson, Bonnie S. [1 ]
Johnson, Faye M. [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-903
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
903
引用
收藏
页数：1
相关论文
共 50 条
  • [41] CAF-secreted COL5A2 activates the PI3K/AKT pathway to mediate erlotinib resistance in head and neck squamous cell carcinoma
    Guo, Yibo
    Chen, Mingtao
    Yang, Jie
    Zhou, Wenkai
    Feng, Guanying
    Wang, Yang
    Ji, Tong
    Zhang, Yu
    Liu, Zheqi
    ORAL DISEASES, 2024,
  • [42] Context-Dependent Regulation of Peripheral Nerve Abundance by the PI3K Pathway in the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma
    Khorani, Karam
    Burkart, Sebastian
    Weusthof, Christopher
    Han, Rui
    Liang, Siyuan
    Stoegbauer, Fabian
    Hess, Jochen
    CELLS, 2024, 13 (12)
  • [43] TAB2 Promotes the Biological Functions of Head and Neck Squamous Cell Carcinoma Cells via EMT and PI3K Pathway
    Liu, Huijuan
    Zhang, Hui
    Fan, Haidong
    Tang, Su
    Weng, Junquan
    DISEASE MARKERS, 2022, 2022
  • [44] PDK1 drives susceptibility of NOTCH1 mutant head and neck squamous carcinoma to PI3K/mTOR pathway inhibition
    Sambandam, Vaishnavi
    Shen, Li
    Peng, Shaohua
    Mazumdar, Tuhina
    Pickering, Curtis
    Myers, Jeffrey
    Wang, Jing
    Frederick, Mitchell
    Johnson, Faye
    CANCER RESEARCH, 2019, 79 (13)
  • [45] Susceptibility of NOTCH1 mutant head and neck squamous carcinoma to PI3K/mTOR pathway inhibition via PDK1
    Sambandam, Vaishnavi
    Frederick, Mitchell J.
    Shen, Li
    Tong, Pan
    Rao, Xiayu
    Peng, Shaohua
    Mazumdar, Tuhina
    Li, Quili
    Pickering, Curtis R.
    Myers, Jeffery N.
    Wang, Jing
    Johnson, Faye M.
    MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 50 - 51
  • [46] Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
    Ruicci, Kara M.
    Plantinga, Paul
    Pinto, Nicole
    Khan, Mohammed I.
    Stecho, William
    Dhaliwal, Sandeep S.
    Yoo, John
    Fung, Kevin
    MacNeil, Danielle
    Mymryk, Joe S.
    Barrett, John W.
    Howlett, Christopher J.
    Nichols, Anthony C.
    MOLECULAR ONCOLOGY, 2019, 13 (10) : 2160 - 2177
  • [47] Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas
    Garcia-Carracedo, Dario
    Angeles Villaronga, M.
    Alvarez-Teijeiro, Saul
    Hermida-Prado, Francisco
    Santamaria, Inigo
    Allonca, Eva
    Suarez-Fernandez, Laura
    Victoria Gonzalez, M.
    Balbin, Milagros
    Astudillo, Aurora
    Martinez-Camblor, Pablo
    Su, Gloria H.
    Pablo Rodrigo, Juan
    Maria Garcia-Pedrero, Juana
    ONCOTARGET, 2016, 7 (20) : 29780 - 29793
  • [48] AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas
    Elkabets, Moshe
    Pazarentzos, Evangelos
    Juric, Dejan
    Sheng, Qing
    Pelossof, Raphael A.
    Brook, Samuel
    Benzaken, Ana Oaknin
    Rodon, Jordi
    Morse, Natasha
    Yan, Jenny Jiacheng
    Liu, Manway
    Das, Rita
    Chen, Yan
    Tam, Angela
    Wang, Huiqin
    Liang, Jinsheng
    Gurski, Joseph M.
    Kerr, Darcy A.
    Rosell, Rafael
    Teixido, Cristina
    Huang, Alan
    Ghossein, Ronald A.
    Rosen, Neal
    Bivona, Trever G.
    Scaltriti, Maurizio
    Baselga, Jose
    CANCER CELL, 2015, 27 (04) : 533 - 546
  • [49] Nanog promotes PI3K/Akt and mTOR-mediated invasion in head and neck squamous cell carcinoma
    Rahimy, Elham
    Yi, David
    Lew, Daniel
    Abhold, Eric
    Kiang, Alan
    Wang-Rodriguez, Jessica
    Ongkeko, Weg
    CANCER RESEARCH, 2012, 72
  • [50] Assessment of phosphatidylinositol-3 kinase (PI3K) as a prognostic marker in head and neck squamous cell carcinoma (HNSCC)
    Pectasides, E.
    Founztilas, G.
    Sasaki, C.
    Burtness, B.
    Psyrri, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345